DEFA14A: Helius Medical Technologies Issues Supplement to Proxy Statement Regarding Quorum Requirements

Helius Medical Technologies releases a supplement to its proxy statement clarifying the quorum requirements for its upcoming Annual Meeting of Stockholders on June 27, 2024.

Summary

• Helius Medical Technologies issued a supplement to its definitive proxy statement on June 20, 2024.
• The supplement amends the proxy statement filed on May 31, 2024, concerning the 2024 Annual Meeting of Stockholders.
• The Annual Meeting will be held virtually on June 27, 2024, at 9:00 a.m. Eastern Time.
• The supplement corrects the description of what constitutes a quorum for the Annual Meeting.
• A quorum requires holders of one-third of the voting power of outstanding shares entitled to vote as of May 28, 2024, to be present.
• Abstentions and broker non-votes will be considered present for quorum determination.
• If a quorum is not reached, the Annual Meeting will be adjourned.
• Stockholders are encouraged to read the supplement together with the Proxy Statement.

Sentiment

Score: 7

Explanation: The document is a neutral, procedural update regarding the company's annual meeting. It corrects a detail about quorum requirements, which is a standard corporate governance matter.

Future Outlook

The document does not contain any specific forward-looking statements beyond the date and time of the annual meeting.

Industry Context

This announcement is a standard procedural update related to corporate governance and shareholder meetings, common for publicly traded companies.

Stakeholder Impact

• Shareholders are directly impacted as the document clarifies the requirements for the Annual Meeting.

Next Steps

• Stockholders should review the supplement and the original proxy statement before voting.
• The company will hold the Annual Meeting on June 27, 2024.

Key Dates

Keywords

Proxy Statement, Annual Meeting, Quorum, Stockholders, Helius Medical Technologies